B

Beeline Medicines

Clinical-stage biotech developing precision autoimmune therapies

Senior Director – Global Regulatory Lead - Regulatory Strategy

Regulatory & Quality (Life Sciences)Updated on Nov 10
Full-timeRemote in USA$242k - $313k

About the Job

Requirements

  • An advanced degree (PhD, PharmD, or master's level) in a relevant life sciences discipline is required.
  • A minimum of 12 years of regulatory affairs experience in the pharmaceutical or biotechnology industry is preferred, with at least 5–7 years of direct responsibility for global regulatory strategy leadership on clinical development programs.
  • Deep expertise in global regulatory strategy development for biologics and/or small molecule therapeutics, with demonstrated experience developing regulatory plans across the FDA, EMA, and additional global jurisdictions from pre-IND through post-approval.
  • Extensive experience preparing and leading Health Authority interactions, including FDA pre-IND, Type B, and Type C meetings and EMA Scientific Advice meetings, with a strong record of productive agency relationships and strategic translation of feedback.
  • Thorough knowledge of FDA regulations (21 CFR Parts 312 and 314/601), EMA regulatory frameworks, ICH E8(R1), ICH E9(R1), and applicable guidance documents relevant to early clinical development in I&I or autoimmune disease indications.
  • Strong strategic thinking skills, intellectual curiosity, and the ability to synthesize complex scientific and regulatory information into clear, actionable regulatory development recommendations.
  • Ability to operate independently, drive execution of regulatory plans with agility and efficiency, exercise sound judgment in stakeholder engagement, keep leadership appropriately informed, and involve senior management at key decision points.
  • Ability to manage multiple concurrent priorities efficiently and with sound judgment, balancing competing timelines and development milestones in a matrix biotechnology organization and recognizing program visibility and criticality in a small-company environment.
  • Written and verbal communication skills, including the ability to translate complex regulatory, scientific, or operational content for executive leadership, Health Authorities, and cross-functional partners.
  • Ability to communicate operational information as clear, actionable insights, provide decisive direction to teams, and drive efficient, aligned execution across functions.
  • Skill in preparing and delivering presentations, briefing documents, and strategic updates to cross-functional leadership teams, board-level stakeholders, and external regulatory agencies.
  • Ability to facilitate productive dialogue in high-stakes meetings, Health Authority interactions, and multi-party collaborations while balancing clarity, diplomacy, and scientific precision.
  • Active listening skills and ability to synthesize input from diverse perspectives into clear, actionable communications that build alignment and drive regulatory decision-making.

Responsibilities

  • Develop and lead integrated global regulatory strategies for assigned pipeline programs in the I&I portfolio, encompassing pre-IND planning, IND/CTA submission strategy, Phase I/II/III development planning, and regulatory pathway optimization across major global jurisdictions including FDA, EMA, PMDA, and others.
  • Serve as the primary regulatory strategist for assigned program teams, providing expert guidance on development plan design, regulatory risk identification, filing sequencing, and Health Authority engagement strategy.
  • Lead the preparation and execution of regulatory meetings, including managing timelines, developing briefing documents, preparing strategically for meetings, and managing agency interactions; translate Health Authority feedback into actionable development recommendations.
  • Develop and maintain integrated regulatory development plans (iRDPs) and regulatory timelines for assigned programs, ensuring alignment with clinical, CMC, and non-clinical development activities and overall program milestones.
  • Lead IND, CTA, NDA, and BLA submissions, regulatory planning, and submission of pediatric development plans.
  • Provide strategic input to clinical protocols, non-clinical study designs, and early CMC development activities to ensure regulatory acceptability and alignment with global development strategy.
  • Monitor and interpret evolving FDA and global regulatory guidance, precedent regulatory decisions, and competitive landscape intelligence relevant to I&I development programs, and proactively integrate insights into pipeline regulatory strategy.
  • Evaluate and leverage expedited regulatory pathway opportunities for pipeline programs, including Breakthrough Therapy Designation, Fast Track Designation, PRIME designation (EMA), and Orphan Drug Designation where applicable.
  • Partner with Regulatory Affairs CMC, Clinical Development, Non-Clinical Sciences, Bioanalytics, and Translational Sciences teams to ensure cross-functional development activities are aligned with regulatory strategy from the earliest stages of development.
  • Contribute to regulatory due diligence for pipeline asset evaluations, in-licensing candidates, and business development targets by assessing regulatory risk profiles, development pathway viability, and filing readiness.
  • Maintain appropriate trackers of regulatory activities.
  • Communicate concisely, clearly, and frequently with cross-functional teams, and lead cross-functional work and regulatory interactions with maturity, finesse, and strategic acumen.
  • Assess resource needs for assigned programs and, with the manager, participate in developing program budgets.
  • Perform other duties and responsibilities as assigned.

Desired Qualifications

  • Prior experience in immunology, inflammation, autoimmune disease, or a related therapeutic area is strongly preferred; knowledge of the lupus regulatory landscape and precedent regulatory decisions is a meaningful advantage.

About the Company

Beeline Medicines

Clinical-stage biotech developing precision autoimmune therapies

Beeline Medicines focuses on precision therapies for autoimmune and inflammatory diseases, advancing a portfolio of in-licensed programs from Bristol Myers Squibb with strong backing from Bain Capital. Its lead, afimetoran, is an oral TLR7/8 inhibitor for lupus, with lomedeucitinib as an allosteric TYK2 inhibitor and two IND-stage biologics targeting IL-18 and IL-10 pathways to modulate immune signaling. The company differentiates itself by combining externally sourced programs with a leadership team experienced in drug development and commercialization, pursuing multiple mechanism-driven candidates rather than a single modality, supported by substantial early funding. Its goal is to move its clinical-stage therapies toward pivotal trials and bring targeted immune-modulating treatments to patients, beginning with completing Phase 2 for afimetoran in late 2026 and following with a pivotal program.

Company size
51-200
Company stage
Series A
Total funding
$426.3M
Headquarters
Stamford, CT
Founded
2025

Recently Posted Jobs

Explore more opportunities at Beeline Medicines

See more jobs